🔥 EMBARK final OS — mature data, real impact
Enzalutamide + ADT improves survival in high-risk BCR prostate cancer
👉 HR 0.60 | ~9% absolute gain
Enza alone? Controls disease… but no OS benefit
👉 Early intensification matters
#MVOnco#ProstateCancer#Oncology
In 2025, many important and long-awaited studies were published. I included them but kept the algorithms unchanged, as there are open questions about how these data will impact practice, particularly in early and metastatic HER2+ disease and mTNBC.
@DFCI_BreastOnc#SABCS25
⚠️ Please donate to provide life saving medical interventions. Thanks for donating to support this young child and help give him a chance at a quality life. ⚠️
Cashapp: SIMAGHEWORLD
Zelle: [email protected]
Paypal: [email protected]
Note 📝 “Emergency surgery at Tamale”
Day 1 of the Kpassa Medical Missions trip has been off to a remarkable start! 🔥
The team was privileged to be immersed into a cultural explosion by the people of Kpassa, Ghana🇬🇭
The team is motivated to continue to engage the community in coming days🔥✝️
Parts of the Komfo Anokye Teaching Hospital have seen a major facelift following massive infrastructural renovations in the Phase 1 of the Heal KATH Project, spearheaded by the Asantehene, Otumfuor Osei Tutu II, as part of his 25th Anniversary Legacy Projects.
🩸 Joining the Lazarex Cancer Wellness Hub and Drexel University for a virtual chat. All are invited!
🩸 Creating awareness about Multiple Myeloma in the community and new advanced therapies available to patients @LazarexCF @DrexelCNHP
Philadelphia is at the forefront of lung cancer treatment, led by experts Dr. @HosseinBorghaei & Dr. Julia Judd. With advanced therapies and personalized care, they’re giving patients renewed hope and tailored options for lung cancer care in our community: https://t.co/xmN3gLQdIg
Creating awareness about Multiple Myeloma in the community and new advanced therapies available to patients🩸
In partnership with Janssen, International Multiple Myeloma Foundation, Health/Hope&Hip-Hop, BHM 🩸@JanssenUS@IMFmyeloma@BHMinfo
We need more options for our patients with 🧬 #KRAS mutant cancers including #colorectalcancer.
💊 Onvansertib
🎯 Polo-like kinase 1 (PLK1)⛔️
PFS~8.4 months. Historically it’s 4-5 months.👇🏽Response rates 10% but 77% in BEV naive. ➡️1st line study planned.
@OncoAlert@JCO_ASCO
👇🏽One more option for our patients. Friday afternoon approval.✔️
Another upper GI biomarker to add to the list of things to 👀 test for.
💡All IHC🔬based
1️⃣HER2
2️⃣MMR
3️⃣CPS-PDL1
4️⃣ #CLAUDIN 18.2 (#CLDN18.2) ✅
5️⃣ FGFR2
#PrecisionMedicine 🎯 @OncoAlert
🤔#MPN with #pregnancy
✅️Management algorithm in myeloproliferative neoplasm
patients who are pregnant or are planning pregnancy
✅️Manage ET in pregnancy
✅️pregnancy and CML
✒️By Gangat
#SOHOKSA
A simple email during my 2nd year @GUMedicine to a faculty mentor has led to this incredible collaboration between neurosurgeons in Ghana and Georgetown. Clipped the first intracranial aneurysm in country’s history!
2x trips to 🇬🇭
#globalneurosurgery#health#neurosurgery